To see the other types of publications on this topic, follow the link: Stomach cancer.

Journal articles on the topic 'Stomach cancer'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Stomach cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Greus, P. Cortina, C. Cortes Vizcaino, J. L. Alfonso Sanchez, D. Carella Piquer, and S. Talamente Serrulla. "Stomach cancer." European Journal of Cancer Prevention 1 (October 1991): 25. http://dx.doi.org/10.1097/00008469-199110001-00042.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Packer, P. J., and S. A. Leach. "Stomach cancer." European Journal of Cancer Prevention 1 (October 1991): 26. http://dx.doi.org/10.1097/00008469-199110001-00043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chan, W. Y. Y., and P. A. Judd. "Stomach cancer." European Journal of Cancer Prevention 1 (October 1991): 26. http://dx.doi.org/10.1097/00008469-199110001-00044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fontana, V., P. Bruzzi, F. Merlo, R. Filiberti, R. Puntoni, A. Giacosa, E. Buiatti, et al. "Stomach cancer." European Journal of Cancer Prevention 1 (October 1991): 27. http://dx.doi.org/10.1097/00008469-199110001-00045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Torpy, Janet M. "Stomach Cancer." JAMA 303, no. 17 (May 5, 2010): 1771. http://dx.doi.org/10.1001/jama.303.17.1771.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Torpy, Janet M. "Stomach Cancer." JAMA 291, no. 2 (January 14, 2004): 266. http://dx.doi.org/10.1001/jama.291.2.266.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Magnusson, Jonas. "Stomach Cancer." Current Surgery 63, no. 2 (March 2006): 96–101. http://dx.doi.org/10.1016/j.cursur.2005.10.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Janet F. "Stomach cancer." Seminars in Oncology Nursing 4, no. 4 (November 1988): 257–64. http://dx.doi.org/10.1016/0749-2081(88)90077-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ratner, Yu A. "Stomach cancer." Kazan medical journal 43, no. 6 (October 19, 2021): 86–87. http://dx.doi.org/10.17816/kazmj83381.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

TILLYASHAYKHOV, M. N., S. M. Djanklich, S. N. Ibragimov, and O. A. Imamov. "Analysis of cancer incidence structure in the Republic of Uzbekistan." Oncologia i radiologia Kazakhstana 61, no. 3 (September 30, 2021): 4–8. http://dx.doi.org/10.52532/2521-6414-2021-3-61-4-8.

Full text
Abstract:
Relevance: Globocan reports 19.3 million new cases of malignant neoplasms in 2020 globally. Mammary gland cancer has become the most commonly diagnosed oncological pathology, followed by lung, colon and rectum, prostate, and stomach cancers. In Uzbekistan, malignant neoplasms of the breast, stomach, cervix, lungs, and brain dominate the structure of cancer incidence. The study aimed to analyze the cancer incidence trends and structure in the Republic of Uzbekistan in 2020. Results: In 2020, 21976 new cancer cases were registered in Uzbekistan. The ratio of men and women newly diagnosed with cancer was 0.7:1.4. Cancers of the breast, cervix, and ovary were the most common in women; cancers of the stomach, lung, and prostate - in men. Hemoblastoses were more common at a young age, breast cancer – at working age, and stomach cancer – at old age. Conclusions: The statistical information analysis showed that in 2020 the cancers of the mammary gland, stomach, and cervix were leading in the overall cancer structure, with significant differences in different age categories. This determines the need for further improvement of cancer care in Uzbekistan.
APA, Harvard, Vancouver, ISO, and other styles
11

Tillyashaykhov, M. N., S. M. Djanklich, S. N. Ibragimov, and O. A. Imamov. "Analysis of cancer incidence structure in the Republic of Uzbekistan." Oncologia i radiologia Kazakhstana 61, no. 3 (October 30, 2021): 4–8. http://dx.doi.org/10.52532/2663-4864-2021-3-61-4-8.

Full text
Abstract:
Relevance: Globocan reports 19.3 million new cases of malignant neoplasms in 2020 globally. Mammary gland cancer has become the most commonly diagnosed oncological pathology, followed by lung, colon and rectum, prostate, and stomach cancers. In Uzbekistan, malignant neoplasms of the breast, stomach, cervix, lungs, and brain dominate the structure of cancer incidence. The study aimed to analyze the cancer incidence trends and structure in the Republic of Uzbekistan in 2020. Results: In 2020, 21976 new cancer cases were registered in Uzbekistan. The ratio of men and women newly diagnosed with cancer was 0.7:1.4. Cancers of the breast, cervix, and ovary were the most common in women; cancers of the stomach, lung, and prostate — in men. Hemoblastoses were more common at a young age, breast cancer – at working age, and stomach cancer – at old age. Conclusions: The statistical information analysis showed that in 2020 the cancers of the mammary gland, stomach, and cervix were leading in the overall cancer structure, with significant differences in different age categories. This determines the need for further improvement of cancer care in Uzbekistan.
APA, Harvard, Vancouver, ISO, and other styles
12

Morton, Lindsay M., Sophie D. Fossa, Marilyn Stovall, Flora E. van Leeuwen, Tom B. Johannesen, Preetha Rajaraman, Berthe M. Aleman, et al. "Stomach cancer risk following radiotherapy for testicular cancer." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 4536. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4536.

Full text
Abstract:
4536 Background: Testicular cancer (TC) is a highly curable malignancy occurring most commonly among men aged 15-34 years. Survivors are at increased risk for adverse late effects of therapy. Previous studies have reported more than 4-fold risks of stomach cancer after TC, although the potential role of radiotherapy and chemotherapy for TC in these associations is unclear. Methods: We evaluated stomach cancer risk in an international cohort of 23,982 men diagnosed with TC during 1959-1987. Using detailed radiotherapy records, doses to the stomach tumor location were estimated for 92 stomach cancer patients and 180 individually matched controls. Chemotherapy drugs and doses also were recorded. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression. Results: Fifty-seven percent of patients with stomach cancer were diagnosed with TC before age 40 years, 65% had seminoma, 95% had stage I or II disease, and 37% were diagnosed with stomach cancer ≥20 years after TC diagnosis. Patients who received radiotherapy [87 (95%) cases, 151 (84%) controls] had a 5.9-fold (95%CI 1.6-21.3) increased risk of stomach cancer compared with patients who did not receive radiotherapy. Risk increased with increasing radiation dose to the stomach (P-trend<0.001), with ORs of 3.6 (95%CI 1.3-10.6), 4.4 (1.2-16.4) and 13.3 (2.5-70.0) after 20-39.9 Gy, 40-49.9 Gy, and ≥50 Gy radiation to the stomach, respectively, compared with <10 Gy. Radiation-related stomach cancer risk did not vary by calendar year of treatment, age at exposure, or TC histology. The OR for having received any chemotherapy was 1.3 (14 cases, 23 controls, 95% CI 0.6-2.8). Stomach cancer risk was not significantly elevated among patients given cisplatin-based chemotherapy (7 cases, 10 controls, OR=1.7, 95% CI 0.6-5.1). Conclusions: Patients administered radiotherapy for TC in the past are at increased risk of developing stomach cancer, particularly those who received ≥20 Gy to the stomach. The study results warrant consideration in radiation risk assessment and long-term follow-up. Future studies should further investigate a possible role for chemotherapy in stomach cancer risk.
APA, Harvard, Vancouver, ISO, and other styles
13

Smailova, Dariga S., Serik E. Ibrayev, Satybaldy N. Muzafarov, Umutzhan S. Samarova, Zaituna A. Khismetova, Farida S. Rakhimzhanova, and Elisa Fabbro. "Data analysis of a pilot screening program for the early detection of esophageal and gastric cancers: retrospective study." Annals of the Russian academy of medical sciences 74, no. 6 (January 21, 2020): 405–12. http://dx.doi.org/10.15690/vramn1109.

Full text
Abstract:
BACKGROUND: According to the WHO, in 2018 stomach cancer was the fifth and esophageal cancer seventh most common cancer in the world. In 2011 the National Screening Program for the Early Detection of Breast, Cervical, and Colorectal Cancer was introduced in Kazakhstan. In 2013 a pilot screening program for the early detection of esophageal and stomach cancers was introduced in Kazakhstan in some regions where there is a low detectability. AIM: Determination of the main causes of low detection of esophageal and stomach cancers in the framework of a pilot screening program in Pavlodar region (Kazakhstan). METHODS: According to the Ministry of Healthcare of the Republic of Kazakhstan, the target group for screening to detect esophageal and stomach cancers was men and women at the aged of 50, 52, 54, 56, 58 and 60 who were not registered as a cancer patient. A retrospective analysis was carried out according to the newly diagnosed cases of esophageal and stomach cancers in Pavlodar region for 20132017. All cases of esophageal and stomach cancers were analyzed to determine the proportion of new cases detected as part of a pilot screening program. RESULTS: 1114 new cases of esophageal and stomach cancers are registered from 2013 to 2017 in Pavlodar region. According to the data in Pavlodar region the average age of newly diagnosed patients with esophageal and stomach cancers was 66 years, M = 65.92 (95 % CI: 65.2466.59) SD = 11.495. During pilot screening program, 135 042 participants were examined; various pathological processes of the esophageal and stomach cancers were detected among 1678 patients, including 97 cancer cases. The detectability of esophageal and stomach cancers from the total number of participants was 0.07 %. Out of 1114 all registered new cases of esophageal and stomach cancers, only 97 new diagnosed cases detected as part of a pilot screening program, reaching 8.7 %, which is considered low. CONCLUSIONS: The main reasons for low detection are administrative barriers. The main barrier of the pilot screening program was the selection of the target group at the age of 50, 52, 54, 56, 58, 60 years old only. Therefore, 15.5 % of newly diagnosed cases of esophageal and stomach cancers were missed due to existing intervals. The second barrier was the use of endoscopes which did not support the function of photo and video archiving of the conducted procedures.
APA, Harvard, Vancouver, ISO, and other styles
14

Gurney, Jason, Diana Sarfati, James Stanley, Clarence Kerrison, and Jonathan Koea. "Equity of timely access to liver and stomach cancer surgery for Indigenous patients in New Zealand: a national cohort study." BMJ Open 12, no. 4 (April 2022): e058749. http://dx.doi.org/10.1136/bmjopen-2021-058749.

Full text
Abstract:
ObjectivesWhen combined, liver and stomach cancers are second only to lung cancer as the most common causes of cancer death for the indigenous Māori population of New Zealand—with Māori also experiencing substantial disparities in the likelihood of survival once diagnosed with these cancers. Since a key driver of this disparity in survival could be access to surgical treatment, we have used national-level data to examine surgical procedures performed on Māori patients with liver and stomach cancers and compared the likelihood and timing of access with the majority European population.Design, participants and settingWe examined all cases of liver and stomach cancers diagnosed during 2007–2019 on the New Zealand Cancer Registry (liver cancer: 866 Māori, 2460 European; stomach cancer: 953 Māori, 3192 European) and linked these cases to all inpatient hospitalisations that occurred over this time to identify curative and palliative surgical procedures. As well as descriptive analysis, we compared the likelihood of access to a given procedure between Māori and Europeans, stratified by cancer and adjusted for confounding and mediating factors. Finally, we compared the timing of access to a given procedure between ethnic groups.Results and conclusionsWe found that (a) access to liver transplant for Māori is lower than for Europeans; (b) Māori with stomach cancer appear more likely to require the type of palliation consistent with gastric outlet obstruction; and (c) differential timing of first stomach cancer surgery between Māori and European patients. However, we may also be cautiously encouraged by the fact that differences in overall access to curative surgical treatment were either marginal (liver) or absent (stomach).
APA, Harvard, Vancouver, ISO, and other styles
15

Chang, Jae Chan. "Perspectives on stomach cancer." Journal of Korean Medical Science 9, no. 4 (1994): 277. http://dx.doi.org/10.3346/jkms.1994.9.4.277.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Pezet, Denis, Pierre Michel, Christine Rebischung, and Marc Ychou. "Cancer of the stomach." Gastroentérologie Clinique et Biologique 30 (September 2006): 16–23. http://dx.doi.org/10.1016/s0399-8320(06)73585-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Purtilo, DavidT, and Fernando Merino. "IMMUNODEFICIENCY AND STOMACH CANCER." Lancet 325, no. 8431 (March 1985): 751. http://dx.doi.org/10.1016/s0140-6736(85)91284-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Elder, J. B. "Cancer of the stomach." Current Opinion in Gastroenterology 1, no. 6 (November 1985): 874–80. http://dx.doi.org/10.1097/00001574-198511000-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

O'Neill, Paul. "Stomach bug causes cancer." Trends in Molecular Medicine 7, no. 11 (November 2001): 491. http://dx.doi.org/10.1016/s1471-4914(01)02210-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Clark, P. I., and M. L. Slevin. "Chemotherapy for stomach cancer." BMJ 295, no. 6603 (October 10, 1987): 870–71. http://dx.doi.org/10.1136/bmj.295.6603.870-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Wanebo, Harold J., B. J. Kennedy, Joan Chmiel, Glenn Steele, David Winchester, and Robert Osteen. "Cancer of the Stomach." Annals of Surgery 218, no. 5 (November 1993): 583–92. http://dx.doi.org/10.1097/00000658-199321850-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Chan, WH, and WK Wong. "Stomach Cancer: An Overview." Cancer Reviews: Asia-Pacific 02, no. 01 (July 2004): 81–91. http://dx.doi.org/10.1142/s021983630400041x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Mathew, A., P. Gangadharan, C. Varghese, and M. K. Nair. "Diet and stomach cancer." European Journal of Cancer Prevention 9, no. 2 (April 2000): 89–98. http://dx.doi.org/10.1097/00008469-200004000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Sun, J., J. Misumi, A. Shimaoka, K. Aoki, and F. Esaki. "Stomach cancer-related mortality." European Journal of Cancer Prevention 10, no. 1 (February 2001): 61–67. http://dx.doi.org/10.1097/00008469-200102000-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Kono, Suminori, and Tomio Hirohata. "Nutrition and stomach cancer." Cancer Causes and Control 7, no. 1 (January 1996): 41–55. http://dx.doi.org/10.1007/bf00115637.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Elder, J. B. "Cancer of the stomach." Current Opinion in Gastroenterology 2, no. 6 (November 1986): 889–95. http://dx.doi.org/10.1097/00001574-198611000-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Barbosa-Lorenzo, Raquel, Juan M. Barros-Dios, and Alberto Ruano-Ravina. "Radon and stomach cancer." International Journal of Epidemiology 46, no. 2 (February 7, 2017): 767–68. http://dx.doi.org/10.1093/ije/dyx011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Toffoli, Giuseppe, and Erika Cecchin. "Pharmacogenomics and stomach cancer." Pharmacogenomics 5, no. 6 (September 2004): 627–41. http://dx.doi.org/10.1517/14622416.5.6.627.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Burr, M. L., and Ruth M. Holliday. "Fruit and stomach cancer." Journal of Human Nutrition and Dietetics 2, no. 4 (August 1989): 273–77. http://dx.doi.org/10.1111/j.1365-277x.1989.tb00029.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Goldner, Fred. "Cancer of the stomach." Gastroenterology 92, no. 6 (June 1987): 2045. http://dx.doi.org/10.1016/0016-5085(87)90653-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Miller, Andrew. "Diet and stomach cancer." Food and Chemical Toxicology 24, no. 5 (May 1986): 437–38. http://dx.doi.org/10.1016/0278-6915(86)90218-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Zhuravleva, N. V., A. V. Samoilova, I. Yu Dolgov, V. N. Diomidova, T. L. Smirnova, O. V. Sharapova, L. I. Gerasimova, et al. "Stomach cancer and pregnancy." Problemy reproduktsii 27, no. 5 (2021): 130. http://dx.doi.org/10.17116/repro202127051130.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Liu, Yu, Yan Zhao, Chongxu Han, and Chuanli Ren. "Expression of CDK6 in Stomach Cancer and the Effect of CDK4/6 Inhibitor PD-0332991 on the Function of Stomach Cancer Cells." Computational and Mathematical Methods in Medicine 2022 (April 30, 2022): 1–8. http://dx.doi.org/10.1155/2022/2402567.

Full text
Abstract:
Objective. To study the expression and prognostic value of CDK6 in stomach cancer and the function of CDK4/6 inhibitor PD-0332991 on the proliferation of stomach cancer cells. Methods. Immunohistochemistry was used to detect the expression of CDK6 in stomach cancer tissues and adjacent normal tissues and to analyze the effect of CDK6 on clinicopathological parameters of stomach cancer patients. Kaplan-Meier plotter was employed to study the relationship between CDK6 and overall survival in stomach cancer. Western blot and RT-PCR were used to detect protein and gene expression of CDK6 in different cells. The effects of CDK4/6 inhibitor PD-0332991 on apoptosis and aging of stomach cancer cells were detected by flow cytometry and β-galactosidase aging staining assay. The effects of CDK4/6 inhibitor PD-0332991 on the invasion and migration of stomach cancer cells were explored by the wound healing experiment and the Transwell experiment. The supernatant of stomach cancer cells was collected, and the effect of CDK4/6 inhibitor PD-0332991 on tumor markers of stomach cancer cells was detected by biochemical immunoassay. Results. (1) CDK6 was highly expressed in stomach cancer tissues and cells. (2) Abnormally elevated CDK6 expression results in shorter survival in stomach cancer patients. (3) CDK4/6 inhibitor PD-0332991 could block the proliferation of stomach cancer cells, but not stomach epithelial proliferation. PD-0332991 could inhibit the secretion of pro-GRP by MGC 823. (4) PD-0332991 could advance the development of the apoptosis and senescence of stomach cancer cells and suppressed the invasion and migration of stomach cancer cells. Conclusion. CDK6 expression is elevated in gastric cancer, and the CDK4/6 inhibitor PD-0332991 can remarkably promote apoptosis and senescence of stomach cancer cells and effectively inhibit the migration and invasion of stomach cancer cells.
APA, Harvard, Vancouver, ISO, and other styles
34

Kawakatsu, Yukino, Yuriko N. Koyanagi, Isao Oze, Yumiko Kasugai, Hisayoshi Morioka, Rui Yamaguchi, Hidemi Ito, and Keitaro Matsuo. "Association between Socioeconomic Status and Digestive Tract Cancers: A Case-Control Study." Cancers 12, no. 11 (November 4, 2020): 3258. http://dx.doi.org/10.3390/cancers12113258.

Full text
Abstract:
Although socioeconomic status (SES) has been associated with cancer risk, little research on this association has been done in Japan. To evaluate the association between SES and digestive tract cancer risk, we conducted a case-control study for head and neck, esophageal, stomach, and colorectal cancers in 3188 cases and the same number of age- and sex-matched controls within the framework of the Hospital-based Epidemiological Research Program at Aichi Cancer Center III (HERPACC III). We employed the education level and areal deprivation index (ADI) as SES indicators. The association was evaluated with odds ratios (ORs) and 95% confidence intervals (CIs) by conditional logistic models adjusted for potential confounders. Even after allowance for known cancer risk factors, the education level showed linear inverse associations with head and neck, stomach, and colorectal cancers. Compared to those educated to junior high school, those with higher education showed statistically significantly lower risks of cancer (0.43 (95% CI: 0.27–0.68) for head and neck, 0.52 (0.38–0.69) for stomach, and 0.52 (0.38–0.71) for colorectum). Consistent with these results for the educational level, the ADI in quintiles showed positive associations with head and neck, esophageal, and stomach cancers (p-trend: p = 0.035 for head and neck, p = 0.02 for esophagus, and p = 0.013 for stomach). Interestingly, the positive association between ADI and stomach cancer risk disappeared in the additional adjustment for Helicobacter pylori infection and/or atrophic gastritis status. In conclusion, a lower SES was associated with an increased risk of digestive cancers in Japan and should be considered in cancer prevention policies for the target population.
APA, Harvard, Vancouver, ISO, and other styles
35

Vishi, Imri, Agron Dogjani, Arben Gjata, Kastriot Haxhirexha, and Hysni Bendo. "Some epidemiological data about Stomach Cancer in Kosovo." Albanian Journal of Trauma and Emergency Surgery 5, no. 2 (July 20, 2021): 864–68. http://dx.doi.org/10.32391/ajtes.v5i2.232.

Full text
Abstract:
Despite the continuing decline in incidence, stomach cancer remains one of the most common and deadly neoplasms in the world [1]. According to the literature, stomach cancer is the third leading cause of cancer deaths worldwide, ranking third after lung cancer and colorectal in global cancer mortality. About 1 in 12 neoplasm deaths can be attributed to stomach cancer, which has 5 times the highest incidence among all cancers, and over one million new cases of stomach cancer are diagnosed each year worldwide.[2] Our objectives were: Evidence and detailed statistical description of demographic, diagnostic, clinical, pathological data of stomach cancer patients are included in this study were hospitalized in two clinical surgery medical centers in the period from January 2009 to January 2019, in University Clinical Center in Prishtina-Department of Surgery, Regional Hospital in Ferizaj-Department of Surgery. Material and methods; The study included 115 patients who met the criteria, and the Study variables were obtained from clinical record data that include: Gender (Male, Female); Age; Clinic of the disease: (indigestion Weakness, Weight loss, anorexia, Melena, Abdominal pain, Epigastric pain, Vomiting…); Tumor stage, histopathologic and lesion type... Conclusion; Stomach cancer affects both sexes with a preference of men with a ratio of 1.4: 1 (M; F). The most affected age group is 51-70 years which includes about 61.3% of patients. Depending on the localization of gastric cancer, the most affected part of our study was the body of the stomach (46%), the antral part 38%, the cardia part with 15.7%. Typical symptoms in our patients included; Indigestion 46 (40%); Loss of appetite 41 (35.6%); Abdominal pain 70(60.8%); Nausea/ vomiting 35( 30.4%); Postprandial pain 39 (33.9%); Weight loss 56 (48.6%); Melena 19 (16.5%)...
APA, Harvard, Vancouver, ISO, and other styles
36

Kerr, William C., and Yu Ye. "US Time Series Evidence regarding Alcohol-Related Risk of Oral Cancers and Protection against Stomach Cancers: Are Higher Concentration Beverages Different?" Contemporary Drug Problems 34, no. 3 (September 2007): 495–511. http://dx.doi.org/10.1177/009145090703400308.

Full text
Abstract:
Autoregressive integrated moving average modeling procedures are utilized on population-level mortality rates for oral and stomach cancers in relation to per capita consumption of total alcohol, beer, wine, spirits and cigarettes to estimate long-term population-level relationships between alcohol consumption series and oral and stomach cancer mortality rates, and to determine whether higher-concentration alcoholic beverages, as represented by spirits, are more strongly related to these cancers than beer or wine. Total alcohol consumption is found to increase oral cancer rates by 3.5% per litre of ethanol. Spirits consumption is found to be the only significant predictor in multivariate models. For stomach cancers, total alcohol and especially spirits are found to be protective, with each litre of spirits associated with a 10% reduction in rates. High-concentration beverages, as represented by spirits, are found to be significant risk factors for oral cancers but potentially protective for stomach cancer.
APA, Harvard, Vancouver, ISO, and other styles
37

Tsukanov, V. V., A. V. Vasyutin, and Yu L. Tonkikh. "Modern Aspects of Stomach Cancer Prevention." Doctor.Ru 19, no. 7 (2020): 37–40. http://dx.doi.org/10.31550/1727-2378-2020-19-7-37-40.

Full text
Abstract:
Objective of the Review: to analyse available data on stomach cancer prevention. Key Points. Key risk factors for stomach cancer are male gender, age of >50 years old, Helicobacter pylori and smoking. A number of international consensus opinions regulate screening, diagnostics and treatment of precancer changes in stomach; it is assumed to reduce the incidence of this disease. H. pylori eradication is the key method of primary stomach cancer prevention. Modern studies demonstrate that the optimal method of H. pylori eradication is the therapy with bismuth medication, proton pump inhibitor, amoxycillin and clarithromycin for 10–14 days. Conclusion. The most efficient method of stomach cancer prevention is H. pylori eradication, smoking cessation, diet with plenty of vegetables and fruit. Secondary prevention is optimisation of diagnostics, follow-up and treatment of precancer stomach conditions. Keywords: stomach cancer, gastratrophia, Helicobacter pylori, prevention.
APA, Harvard, Vancouver, ISO, and other styles
38

Kobia, Francis, Jesse Gitaka, Francis Makokha, Moses Kamita, Joshua Kibera, Cynthia Mwenda, Gladys Mucee, and Bactrin Kilingo. "The state of cancer in Meru, Kenya: a retrospective study." AAS Open Research 2 (December 3, 2019): 167. http://dx.doi.org/10.12688/aasopenres.13027.1.

Full text
Abstract:
Background: It is projected that by 2030, 70% of all cancer related deaths will occur in low-middle income countries. However, data on the state of cancer in most African countries is scanty. Cancer estimates for Kenya are based on the Nairobi and Eldoret cancer registries, leaving most parts of the country unrepresented. Lacking national coverage, these data do not accurately reflect Kenya’s cancer burden. The paucity of reliable data impedes formulation of effective cancer control strategies and cancer research prioritization. Here, we report the findings of a retrospective study of the cancer state in Meru County, Kenya. Methods: A retrospective analysis of patient files at Meru hospice was carried out. 2349 cancer cases seen at the Meru hospice between 2003 and 2018 were analyzed. Data abstracted from the records included patient age, gender and cancer type. The abstracted data was analyzed by descriptive statistics. Results: Our results indicate that cancer is almost evenly distributed across genders, with men accounting for 49% and women 51%. Stomach cancer rates are strikingly elevated and equal to those in countries with the highest stomach cancer rates globally – making it the commonest cancer in this region (14%). Among men, the most common cancers affect the prostate (18%), stomach (17%), esophagus (14%), head & neck (12%), liver (8%) and colorectum (5%). Among women, the commonest are cancers of the breast (22%), cervix (20%), stomach (11%), esophagus (8%), head & neck (6%) and liver (5%). Breast cancer occurs at a notably early age, with 20% of those affected aged below 40. Lung cancer rates are notably low in this region (1.3%) relative to world estimates. Conclusion: Cancer distribution in Meru is nearly even between sexes. Our analysis suggests that the Meru region is a stomach cancer hotspot and that it also experiences elevated esophageal cancer levels.
APA, Harvard, Vancouver, ISO, and other styles
39

Shin, Cheol Min, Nayoung Kim, Hyo Jun Yang, Sung-Il Cho, Hye Seung Lee, Joo Sung Kim, Hyun Chae Jung, and In Sung Song. "Stomach Cancer Risk in Gastric Cancer Relatives." Journal of Clinical Gastroenterology 44, no. 2 (February 2010): e34-e39. http://dx.doi.org/10.1097/mcg.0b013e3181a159c4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Inoue, Haruhiro. "Endoscopic Mucosal Resection for Esophageal and Gastric Mucosal Cancers." Canadian Journal of Gastroenterology 12, no. 5 (1998): 355–59. http://dx.doi.org/10.1155/1998/535978.

Full text
Abstract:
Accumulated data from surgically resected specimens reveal that mucosal cancers of the esophagus and stomach pose low risk of lymph node metastasis. The author used endoscopic mucosal resection (EMR) as curative treatment in 142 cases of esophageal cancer and 102 cases of stomach cancer. In absolutely indicated cases there has been no local or distant metastasis during the longest period of follow-up (nine years). One perforation and one post-treatment severe stenosis, which was resistant to dilation therapy in the esophagus, were encountered. Deeper layer resection (including partial proper muscle) occurred in the stomach in three cases where the lesions were positioned to the lesser curvature of the upper part of the stomach. Two cases of gastric mucosal resection leaving residual cancer were successfully treated by laser ablation. No case has required further surgery. Resected specimens were contributed to histological evaluation in all cases. In conclusion, EMR can be considered as the first-line treatment for selected cases of early stage esophageal and stomach cancer.
APA, Harvard, Vancouver, ISO, and other styles
41

Kogoniya, L. M., L. E. Gurevich, V. S. Mazurin, and E. V. Markarova. "Experience of long-term clinical observation of a patient with a rare type of stomach cancer – lymphoepithelioma-like carcinoma." Meditsinskiy sovet = Medical Council, no. 9 (July 30, 2020): 277–82. http://dx.doi.org/10.21518/2079-701x-2020-9-277-282.

Full text
Abstract:
Stomach cancer is one of the most frequently diagnosed cancers. The success of special methods of treatment are still disappointing in this disease, and stomach cancer has historically been considered a tumor refractory to treatment. Therefore, this category of patients, especially in the stage of dissemination, in most cases, palliative therapy is recommended. In recent years, the use of systemic chemotherapy and targeted therapy has led to a significant improvement in the quality of life and survival rates for stomach cancer compared to palliative therapy. However, significant progress in diagnostic methods over the past two decades has made it possible and possible to review approaches to the treatment of many cancer diseases that are refractory to chemotherapy. The last 2 decades, due to improved methods of diagnosis have allowed to revise approaches to the treatment of many refractory to chemotherapy of neoplastic diseases. In particular, the literature describes cases of revision and changes due to pre-existing diagnosis of IHC Research (carcinoid, NEO, stomach cancer, pancreatic cancer). This communication allows to share their own long experience of observation and treatment of a patient with a rare form of stomach cancer – lymphoepithelioma-like carcinoma.
APA, Harvard, Vancouver, ISO, and other styles
42

Toyoda, Yasuhiro, Takahiro Tabuchi, Hitomi Hama, Toshitaka Morishima, and Isao Miyashiro. "Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix." PLOS ONE 15, no. 12 (December 31, 2020): e0244644. http://dx.doi.org/10.1371/journal.pone.0244644.

Full text
Abstract:
We examined clinical stage distribution and proportion of screen-detected cases of stomach, colorectal, lung, female breast and cervical cancer by sex and age group using Osaka Cancer Registry data from 2000–2014. The proportion of local or in situ stage cancer had increased for all age groups in all sites, except stomach cancer in the 0–49 years group and female breast cancer in the 80 years and older group. The proportion of screen-detected cases had increased during the study period for all age groups in all cancer sites. While the proportion increased noticeably in the younger groups, there was only a slight increase in the older groups. Regarding stomach, colorectal and lung cancers, the proportion of local and in situ stage had similarly increased in the 65–79 years and 80 years and older age groups compared with younger groups, despite lower exposure to cancer screening. Regarding breast and cervical cancers, the increases in local and in situ cancer paralleled the increase in screen-detected cases. These findings suggest that the increases in early stage stomach, colorectal and lung cancers might be due not only to the expansion of screening programs but also the development of clinical diagnostic imaging or other reasons. The increases in local and in situ stage breast and cervical cancers seemed to be due to the expansion of screening. Continued monitoring of trends in cancer incidence by clinical stage may be helpful for estimating the effectiveness of screening.
APA, Harvard, Vancouver, ISO, and other styles
43

Chornobay, A. V., and M. A. Chornobay. "THERAPEUTIC TREATMENT OF STOMACH CANCER." Bulletin of Problems Biology and Medicine 1, no. 1 (2019): 70. http://dx.doi.org/10.29254/2077-4214-2019-1-1-148-70-75.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Seppa, Nathan. "Antibiotics, Vitamins Stall Stomach Cancer." Science News 158, no. 25 (December 16, 2000): 389. http://dx.doi.org/10.2307/4018568.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Agranovich, Ilana M., Aleksandr P. Khorovodov, Aysel T. Mamedova, Anastasia A. Shnitenkova, Veronika E. Shimanova, Nikita A. Novolokin, Tatiana S. Vashenko, et al. "Photodynamic Diagnostics of Stomach Cancer." Izvestiya of Saratov University. New Series. Series: Chemistry. Biology. Ecology 19, no. 1 (2019): 50–57. http://dx.doi.org/10.18500/1816-9775-2019-19-1-50-57.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Cho, Joo-Young. "Endoscopic Treatment of Stomach Cancer." Journal of the Korean Medical Association 45, no. 2 (2002): 148. http://dx.doi.org/10.5124/jkma.2002.45.2.148.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

KAMIYAMA, Shigetoshi. "Stomach Cancer and Dietary Habits." JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE 41, no. 6 (1993): 1125–33. http://dx.doi.org/10.2185/jjrm.41.1125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Halperin, DavidC, M. E. Belgrade, and Alejandro Mohar. "STOMACH CANCER CLUSTER IN MEXICO." Lancet 331, no. 8593 (May 1988): 1055. http://dx.doi.org/10.1016/s0140-6736(88)91876-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Forman, D. "Stomach cancer - an infectious disease?" European Journal of Cancer 37 (April 2001): S248. http://dx.doi.org/10.1016/s0959-8049(01)81408-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Wu, C.-W., W.-Y. Lui, F.-K. P'Eng, and C.-W. Chi. "Hormonal therapy for stomach cancer." Medical Hypotheses 39, no. 2 (October 1992): 137–39. http://dx.doi.org/10.1016/0306-9877(92)90173-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography